Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1988-3-15
pubmed:abstractText
Thirty-four hospitalized patients with major depression were enrolled in a 3-week double-blind parallel comparative study of trimipramine and amitriptyline. Following a 1-week washout period, patients randomly received one of the two drugs up to 100 mg twice daily on a fixed increment dosage schedule. Both treatments produced a rapid significant clinical improvement that occurred in a predominantly linear fashion. The pattern of improvement was very similar with both drugs. There was no significant correlation between plasma levels of trimipramine and desmethyl-trimipramine and clinical improvement. A negative correlation between amitriptyline plasma levels and clinical improvement was found, whereas a positive correlation occurred with the nortriptyline levels. Amitriptyline, and to a lesser extent trimipramine, prolonged intracardiac conduction. In the amitriptyline group only, this effect was accompanied by significant increases of heart rate and blood pressure. Platelet serotonin content was decreased by 57% by the amitriptyline treatment but remained unchanged in the trimipramine group. This finding constitutes the first clinical evidence that trimipramine does not exert its antidepressant effect through 5-hydroxytryptamine reuptake blockade. It is proposed that neuronal sensitization to 5-hydroxytryptamine might mediate the therapeutic effect of tricyclic antidepressant drugs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0271-0749
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
385-93
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3323262-Adult, pubmed-meshheading:3323262-Aged, pubmed-meshheading:3323262-Amitriptyline, pubmed-meshheading:3323262-Blood Pressure, pubmed-meshheading:3323262-Clinical Trials as Topic, pubmed-meshheading:3323262-Depressive Disorder, pubmed-meshheading:3323262-Dexamethasone, pubmed-meshheading:3323262-Dibenzazepines, pubmed-meshheading:3323262-Double-Blind Method, pubmed-meshheading:3323262-Electrocardiography, pubmed-meshheading:3323262-Female, pubmed-meshheading:3323262-Humans, pubmed-meshheading:3323262-Male, pubmed-meshheading:3323262-Middle Aged, pubmed-meshheading:3323262-Psychiatric Status Rating Scales, pubmed-meshheading:3323262-Random Allocation, pubmed-meshheading:3323262-Serotonin Antagonists, pubmed-meshheading:3323262-Trimipramine, pubmed-meshheading:3323262-Tryptophan
pubmed:year
1987
pubmed:articleTitle
A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
pubmed:affiliation
Psychiatric Research Center, Louis-H. Lafontaine Hospital, Montreal, Quebec, Canada.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial